Detalhe da pesquisa
1.
Dual epigenetic agents plus rituximab-gemcitabine-oxaliplatin as salvage treatment in relapsed/refractory diffuse large B-cell lymphoma patients failure of salvage chemotherapy.
Hematol Oncol
; 40(5): 914-921, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35856472
2.
CAR-T therapy bridging to allogeneic HSCT provides durable molecular remission of Ph+ mixed phenotype acute leukaemia with minimal residual disease.
Br J Haematol
; 191(2): e47-e49, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32700338
3.
Trimeric G protein-CARMA1 axis links smoothened, the hedgehog receptor transducer, to NF-κB activation in diffuse large B-cell lymphoma.
Blood
; 121(23): 4718-28, 2013 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-23632891
4.
Transcriptional regulation of serine/threonine protein kinase (AKT) genes by glioma-associated oncogene homolog 1.
J Biol Chem
; 288(21): 15390-401, 2013 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-23580656
5.
Donor origin CAR19 T cell infusion for B-ALL relapsed after allogeneic hematopoietic stem cell transplantation.
Hematol Oncol
; 37(5): 655-658, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31656047
6.
Role of radiation in chimeric antigen receptor T-cell therapy for patients with relapsed/refractory non-Hodgkin lymphoma: Current studies and future prospects.
Crit Rev Oncol Hematol
; 199: 104390, 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38782146
7.
Computer-aided diagnostic system with automated deep learning method based on the AutoGluon framework improved the diagnostic accuracy of early esophageal cancer.
J Gastrointest Oncol
; 15(2): 535-543, 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38756633
8.
Functional inhibition of BCL2 is needed to increase the susceptibility to apoptosis to SMO inhibitors in diffuse large B-cell lymphoma of germinal center subtype.
Ann Hematol
; 92(6): 777-87, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23370596
9.
Body mass index-associated responses to an ABVD-like regimen in newly-diagnosed patients with Hodgkin lymphoma.
Front Pharmacol
; 14: 1195907, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37680722
10.
Efficacy and safety of chimeric antigen receptor T cell therapy in relapsed/refractory diffuse large B-cell lymphoma with different HBV status: a retrospective study from a single center.
Front Immunol
; 14: 1200748, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37292195
11.
Long-term Complete Remission of Decitabine-Primed Tandem CD19/CD22 CAR-T Therapy with PD-1 and BTK Inhibitors Maintenance in a Refractory Primary Central Nervous System Lymphoma Patient.
Cancer Res Treat
; 55(4): 1363-1368, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37321275
12.
Circulating tumor DNA determining hyperprogressive disease after CAR-T therapy alarms in DLBCL: a case report and literature review.
Front Oncol
; 13: 1283194, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38090479
13.
Overall survival benefits provided by lenalidomide maintenance after chimeric antigen receptor T cell therapy in patients with refractory/relapsed diffuse large B-cell lymphoma.
Ann Transl Med
; 10(6): 298, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35433994
14.
Efficacy and toxicity of SEAM (semustine, etoposide, cytarabine, and melphalan) conditioning regimen followed by autologous stem cell transplantation in lymphoma.
Hematology
; 27(1): 404-411, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35413224
15.
Decitabine-primed tandem CD19/CD22 CAR-T therapy in relapsed/refractory diffuse large B-cell lymphoma patients.
Front Immunol
; 13: 969660, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36059523
16.
Successful application of PD-1 knockdown CLL-1 CAR-T therapy in two AML patients with post-transplant relapse and failure of anti-CD38 CAR-T cell treatment.
Am J Cancer Res
; 12(2): 615-621, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35261791
17.
Chimeric antigen receptors containing the OX40 signalling domain enhance the persistence of T cells even under repeated stimulation with multiple myeloma target cells.
J Hematol Oncol
; 15(1): 39, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35365211
18.
Multiple blood parameters may serve as a warning to immunochemotherapy-related interstitial lung disease in B-cell lymphoma.
Ann Palliat Med
; 10(9): 9660-9668, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34628891
19.
Low-dose decitabine as part of a modified Bu-Cy conditioning regimen improves survival in AML patients with active disease undergoing allogeneic hematopoietic stem cell transplantation.
Bone Marrow Transplant
; 56(7): 1674-1682, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33637882
20.
CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.
J Hematol Oncol
; 14(1): 82, 2021 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34034795